Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Technology:
AgeTech Companies
Headquarters:
United Kingdom
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
N/A
Number Of Exists:
N/A
Employee Number:
N/A
Industry:
UK AgeTech 2020
Investor Type:
N/A